Saregama India Intrinsic Value
Saregama India (SAREGAMA) median intrinsic value is ₹556.70 from 10 valuation models (range ₹150–₹1000), vs current price ₹499.90 — +11.4% upside (Trading Below Median Value), margin of safety 10.2%. For current market price and key ratios, visit Saregama India stock price NSE.
SAREGAMA Valuation Methods Summary — DCF, Graham Number & P/E
Saregama India intrinsic value across 10 models vs current price ₹499.90 — upside/downside and value range per method. See SAREGAMA P/B ratio to compare market price against book value per share.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹231.60 | ₹185.28 - ₹277.92 | -53.7% | EPS: ₹15.44, Sector P/E: 15x |
| Book Value Method | asset | ₹892.11 | ₹802.90 - ₹981.32 | +78.5% | Book Value/Share: ₹892.11, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹625.26 | ₹562.73 - ₹687.79 | +25.1% | Revenue/Share: ₹625.26, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹999.80 | ₹899.82 - ₹1099.78 | +100.0% | EBITDA: ₹516.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹426.72 | ₹341.38 - ₹512.06 | -14.6% | CF Growth: 1.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹149.97 | ₹134.97 - ₹164.97 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹159.03 | ₹143.13 - ₹174.93 | -68.2% | Revenue Growth: 6.0%, Adj P/E: 10.3x |
| ROE Based Valuation | profitability | ₹999.80 | ₹899.82 - ₹1099.78 | +100.0% | ROE: 17.5%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹556.70 | ₹501.03 - ₹612.37 | +11.4% | EPS: ₹15.44, BVPS: ₹892.11 |
| Dividend Yield Method | dividend | ₹150.00 | ₹135.00 - ₹165.00 | -70.0% | DPS: ₹4.50, Target Yield: 3.0% |
SAREGAMA Intrinsic Value vs Market Price — All Valuation Models
Saregama India fair value range ₹150–₹1000 vs current market price ₹499.90 across 10 valuation models. Check SAREGAMA market value to track the company's total market size over time.
SAREGAMA Intrinsic Value Analysis — Undervalued or Overvalued?
Saregama India median intrinsic value ₹556.70, current price ₹499.90 — Trading Below Median Value by 11.4%, margin of safety 10.2%.
What is the intrinsic value of SAREGAMA?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Saregama India (SAREGAMA) is ₹556.70 (median value). With the current market price of ₹499.90, this represents a +11.4% variance from our estimated fair value.
The valuation range spans from ₹149.97 to ₹999.80, indicating ₹149.97 - ₹999.80.
Is SAREGAMA undervalued or overvalued?
Based on our multi-method analysis, Saregama India (SAREGAMA) appears to be trading below median value by approximately 11.4%.
SAREGAMA Financial Health — Key Ratios vs Industry Benchmarks
Saregama India financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.63 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 17.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 42.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.51x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SAREGAMA Cash Flow Quality — Operating & Free Cash Flow
Saregama India operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹100 Cr | ₹45 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹331 Cr | ₹221 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹93 Cr | ₹93 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹93 Cr | ₹16 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹94 Cr | ₹-221 Cr | Positive Operating Cash Flow | 6/10 |